Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04577807
Title PVSRIPO With or Without Immune Checkpoint Blockade in Patients With Advanced PD-1 Refractory Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istari Oncology, Inc.
Indications

skin melanoma

mucosal melanoma

Therapies

PVSRIPO + unspecified PD-1 antibody

PVSRIPO

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.